Pharis Mohideen
Chief Tech/Sci/R&D Officer chez DBV TECHNOLOGIES
Fortune : 118 152 $ au 31/03/2024
Provenance du réseau au premier degré de Pharis Mohideen
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 29 | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.
16
| Subsidiary | Pharmaceuticals: Major | 16 |
| Extinct | Pharmaceuticals: Major | 9 | |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Shionogi, Inc.
 Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi, Inc. is a pharmaceutical company based in Florham Park, NJ. Since 1878, the private company has been utilizing science to address health challenges and has discovered several novel antibiotics and medications for HIV and influenza. Shionogi conducts ongoing research into established products and new antibiotic compounds, as well as developing an investigational antiviral for COVID-19. The company is committed to pursuing discovery through partnerships, including collaboration with scientists through investigator-initiated research. Shionogi is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs in infectious disease and other areas of high medical need including neurology and cardiovascular disease. Nathan McCutcheon has been the CEO of the company since 2019.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Pharis Mohideen via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| CELGENE | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| HUMANIGEN, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO Corporate Officer/Principal | |
| IPSEN | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
FORMA Therapeutics, Inc.
 FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
Millendo Therapeutics US, Inc.
 Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI. | Pharmaceuticals: Major | Director/Board Member Director/Board Member President Corporate Secretary Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Treasurer Director of Finance/CFO Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Graduate Degree | |
| UCB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| SANOFI INDIA LIMITED | Pharmaceuticals: Major | Director of Finance/CFO | |
| OXFORD BIOMEDICA PLC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| Imperial College London | College/University | Graduate Degree Doctorate Degree | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Chairman | |
| University of Wisconsin | College/University | Doctorate Degree Undergraduate Degree | |
| State University of New York at Albany | College/University | Doctorate Degree Undergraduate Degree | |
| University of Maryland | College/University | Undergraduate Degree Doctorate Degree | |
| University of Michigan | College/University | Graduate Degree Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Home Biosciences SAS
 Home Biosciences SAS BiotechnologyHealth Technology Home Biosciences SAS is a biotech venture builder that partners with academics and scientists to develop life-changing therapies for patients. The company is based in France and has subsidiaries in the country. The French company's operating model allows its teams to focus on scientific and operational excellence to expedite and de-risk the discovery and development paths of its projects, which are housed in dedicated ventures and fully financed by Home Biosciences. Home Biosciences was founded in 2019 by Magali Richard and David S. Schilansky, who has been the CEO since its inception. | Biotechnology | Chief Executive Officer Founder | |
| EUROAPI | Biotechnology | Director/Board Member Chairman | |
| NEON THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| IDORSIA LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| AXCA HEALPAR | Biotechnology | Chairman Chief Executive Officer | |
| SHATTUCK LABS, INC. | Biotechnology | Chairman Director/Board Member | |
The Mount Sinai Hospital
 The Mount Sinai Hospital Hospital/Nursing ManagementHealth Services The Mount Sinai Hospital provides medical and healthcare services. The company was founded in 1952 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
| EUROBIO SCIENTIFIC | Medical Specialties | Director/Board Member | |
| ICN Business School | College/University | Undergraduate Degree | |
| William Paterson University | College/University | Undergraduate Degree | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| SENTI BIOSCIENCES, INC. | Director/Board Member | ||
| Ecole Supérieure de Gestion | College/University | Masters Business Admin | |
Cellestia Biotech AG
 Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 32 |
| France | 8 |
| Suisse | 4 |
| Royaume-Uni | 4 |
| Allemagne | 2 |
Sectorielle
| Health Technology | 36 |
| Consumer Services | 10 |
| Commercial Services | 3 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 276 |
| Corporate Officer/Principal | 145 |
| Independent Dir/Board Member | 90 |
| Director of Finance/CFO | 47 |
| Chairman | 46 |
Relations les plus connectées
| Insiders | |
|---|---|
| George Golumbeski | 36 |
| David Epstein | 28 |
| Michel de Rosen | 28 |
| Torbjørn Bjerke | 27 |
| Carole Nüchterlein | 26 |
| Mary Lynne Hedley | 24 |
| Helen Boudreau | 22 |
| Timothy Morris | 21 |
| Maïlys Ferrère | 21 |
| Viviane Monges | 21 |
| John P. Howe | 20 |
| Andreas Rummelt | 18 |
| Claire Giraut | 16 |
| Julie O'Neill | 16 |
| Daniel Tassé | 16 |
- Bourse
- Insiders
- Pharis Mohideen
- Connexions Sociétés
